NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
The Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) was established in 1992 by the Minnesota State Legislature as a non-partisan, independent body charged with assessing new and existing health care technologies and applying a Minnesota perspective.
These assessments are based on evaluations of existing research and assessments of technology, providing balanced, objective information important to the entire health care system.
Contents
- Autologous Chondrocyte Implantation for Chondral Knee DamageCreated: September 1999.
- Automatic External Defibrillators (AED)Created: March 1999.
- Bone Densitometry as a Screening Tool for Osteoporosis in Postmenopausal
WomenCreated: August 1997.
- Introduction
- Background
- Findings
- Cost-Analyses of Bone Densitometry as a Screening Tool for Osteoporosis
- Bone Densitometry in Minnesota
- Conclusions
- Recommendations
- Appendix I: Bone Density Screening Techniques
- Appendix II: Equipment Costs and Average Charge Per Scan
- Appendix III: Treatments for Osteoporosis
- Appendix IV: Guidelines from other sources
- Appendix V: Distribution Plan
- Appendix VI: Public Comments on Preliminary HTAC Report
- Appendix VII: Summary of Public Testimony
- References
- Cadaver Donor Pancreas Transplantation for Poorly Controlled Type I
DiabetesCreated: July 1996.
- Dental ImplantsCreated: February 2000.
- Detection of Coronary Artery Disease (CAD) with Electron Beam Computed Tomography (EBCT)Created: October 1997.
- Fetal Heart Rate Assessment During LaborCreated: January 1996.
- Executive Summary
- Technical Report
- Appendix I Hayes Directory of New Medical Technologies' Status Legal Precendent ReportElectronic Fetal Monitoring During Labor
- Appendix II Public Comments on Preliminary Report
- Appendix III Public Testimony Taken bythe Minnesota Health Care Commission onJanuary 17, 1996 Regarding HTAC's Final TechnologyEvaluation Report
- References
- Genetic Testing for Susceptibility to Breast CancerCreated: June 1998.
- Introduction
- Background
- Tests for Susceptibility to Breast Cancer
- Genetic Testing and Patient Outcome
- Cost-effectiveness of Genetic Testing
- Unresolved Issues in Genetic Testing for Susceptibility to Breast Cancer
- Findings
- Recommendations
- Appendix I : Recommendations of Professional Groups Regarding Genetic Testing
- Appendix II: Report Distribution Plan
- References
- Helical Computed Tomography (CT) for Lung Cancer Screening of Asymptomatic PatientsCreated: December 2000.
- Executive Summary
- Background
- Patient Selection Criteria
- Findings
- Quality of Evidence
- Technical Issues
- Credentialing and Licensing
- Safety
- Cost and Cost-effectiveness
- Future of Procedure
- Conclusions
- Recommendations
- Appendix I: Recommendations from Government Agencies and Professional Organizations Regarding Helical CT Scanners
- Appendix II: Methodology
- Appendix III: Clinical Studies Evaluating Helical Computed Tomography for Lung Cancer Screening
- Appendix IV: Public Comment
- References
- High-Dose Chemotherapy with Autologous Bone Marrow Transplantation and/or
Peripheral Blood Stem Cell Transplantation for Breast CancerCreated: August 1996.
- Human Immunodeficiency Virus (HIV) Testing for Pregnant WomenCreated: June 1997.
- Human Immunodeficiency Virus (HIV) Testing for Pregnant Women
- Introduction
- Background
- Transmission of HIV from Women to Their Infants
- Prevalence of HIV Infection in Women and Children in the United States and Minnesota
- Prevention of Mother-to-Infant HIV Transmission
- HIV Testing Program Components and Treatment Needs
- Comparison of HIV Testing Alternatives
- Economic Considerations of HIV Testing in Pregnant Women
- Summary and Recommendations
- Appendix I. Comparison in the Rate of HIV Positive Women Delivering Infants andPerinatal HIV TransmissionUnited States and Minnesota
- Appendix II. HIV Prevalence for Childbearing Women by Area of Residence of Mother for the State of Minnesota 1988-1996Rate per 10,000 Population (95 Percent Confidence Interval)
- Appendix III
- Appendix IV
- Appendix V
- Appendix VI. Adaptation of a Model For Economic Impact of Testing And Treating HIV Positive Pregnant Women And Their Babies in Minnesota
- Appendix VII
- Appendix VIII
- REFERENCES
- Implantable Neurostimulation DevicesCreated: September 1998.
- Intradiscal Electrothermal Therapy (IDET) for Lower Back PainCreated: March 2001.
- In Vitro Fertilization As A Medical Treatment For Male or Female InfertilityCreated: May 1997.
- Light Therapy for Seasonal Affective Disorder (SAD)Created: February 2001.
- MMR Vaccine and Autism: No Evidence of AssociationCreated: June 2001.
- Neuroimaging to Evaluate Headache: Computed Tomography (CT) and Magnetic
Resonance Imaging (MRI)Created: November 1995.
- Introduction
- Types of Headache
- Diagnosis of Headache
- FDA Approval
- Public Agencies and Professional Associations
- Review of Evidence
- Review of Evidence: Alternative Technologies
- Conclusions: Net Health Outcome
- Evaluation of Cost Effectiveness
- Conclusions: Comparison of Cost
- Other Considerations
- Appendix I
- Appendix II. Hayes Directory of New Medical Technologies' Status Legal Precedent Report
- Summary
- Materials Found Directly Related to Insurance Coverage
- Materials Found Indirectly Related to Insurance Coverage
- Materials Found Directly Related to Medical Malpractice
- Materials Found Indirectly Related to Medical Malpractice
- Appendix A. Health Technology Advisory Committee (HTAC)
- Appendix B. Public Comments on Preliminary Report
- References
- New Technologies for Cervical Cancer ScreeningCreated: January 1999.
- Executive Summary
- Introduction
- Background
- Pap Smear Methods
- Strategies To Lower The Rate Of Cervical Cancer
- Review of Peer-Reviewed, Published Literature
- Other Technology Reports
- Conclusions
- Recommendations
- Appendix I: Classification Systems for Cervical Cytology
- Appendix II: Summary of Clinical Laboratory Regulations of the Clinical Laboratory Improvement Amendments of 1988 (CLIA)
- Appendix III: Findings from the Medical Literature
- Appendix IV: Public Comment
- References
- New Vaccinations: Lyme Disease, Rotavirus, Hepatitis A and Pneumococcal DiseaseCreated: December 1999.
- Positron Emission Tomography (PET) for Oncologic ApplicationsCreated: March 1999.
- Executive Summary
- Introduction
- Background
- Cost of Pet
- Issues of Controversy
- Future of PET
- Conclusions
- Recommendations
- Appendix I: Radiotracers Used and Types of PET Image Analysis
- Appendix II: Studies Assessing the Utility of PET
- Appendix III: Clinical Studies Summaries
- Appendix IV: Government Agencies and Professional Organizations
- Appendix V: Public Comments
- Acronyms and Abbreviations
- References
- Post-Delivery Care and Stabilization of Mother and NewbornCreated: April 1996.
- Executive Summary
- Technical Report
- APPENDIX I: Glossary
- APPENDIX II: Summary of Reviewed Articles
- APPENDIX III: Health Plan Policies
- APPENDIX IV: Minnesota Statistics
- APPENDIX V:Minnesota Statutes 199662a.0411 Maternity Care
- APPENDIX VI:Public Comments on Preliminary Report
- APPENDIX VII:Public Testimony Taken by the Minnesota Health CareCommissionon March 20, 1996, Regarding HTAC's FinalTechnology Evaluation Report
- References
- Preoperative Autologous Blood Donation (PABD)Created: September 2000.
- Preventive Therapies for Women at Increased Risk for Breast CancerCreated: September 1999.
- Executive Summary
- Introduction
- Risk Factors
- Preventive Therapies: Selective Estrogen Receptor Modulators (SERMS)
- Preventive Therapies: Mastectomy
- Costs and Cost-effectiveness
- Statements of Professional Organizations
- Recommendations
- Appendix I: Breast Cancer Risk Factor Groups from Hartmann et al study
- Appendix II: National Cancer Institute (NCI): Guidelines for Preventive Mastectomy
- Appendix III: Public Comment
- References
- Radiographic Absorptiometry as a Diagnostic and Management Tool for OsteoporosisCreated: November 1997.
- Refractive Eye Surgery for MyopiaCreated: June 1999.
- St. John's WortCreated: December 2000.
- Executive Summary
- Introduction
- FDA
- Background
- Uses
- Findings
- Dosage
- Safety
- Issues of Controversy
- Cost
- Conclusions
- Recommendations
- Appendix I: Summary of Studies
- Appendix II: Side Effects, Adverse Effects, Precautions, and Warnings
- Appendix III: Selected Information Resources
- Appendix IV: Foods Containing the AminoAcids Tryptophan and Tyrosine
- Appendix V: Cost Comparison
- Appendix VI: Description of Hamilton Rating Scale and Clinical Global Impressions Scale
- Appendix VII: Public Comments
- References
- Stereotactic Radiosurgery: Neurological ApplicationsCreated: June 1995.
- Surgical Alternatives to Hysterectomy for Abnormal Uterine BleedingCreated: June 2000.
- Executive Summary
- Medical Background
- Surgical Treatments
- Patient Selection Criteria
- Pre-operative Preparation
- Endometrial Ablation Techniques
- Endometrial Ablation Compared to Hysterectomy
- Endometrial Ablation Compared to Drug Treatment
- Safety
- Issues of Controversy
- Costs And Cost-effectiveness
- Conclusions
- Recommendations
- Appendix I: Methodology
- Appendix II: Government Agencies And Professional Organizations Guidelines
- Appendix III: Randomized Controlled Trials on the Efficacy of TCRE versus Hysterectomy
- Appendix IV: Clinical Studies on the Efficacy of ELA
- Appendix V: Clinical Studies on the Efficacy of TBEA
- Appendix VI: Randomized Controlled Trials on the Efficacy of EA versus Standard Treatment
- Appendix VII: Public Comment
- References
- Thrombolytic Therapy for Acute Myocardial InfarctionCreated: May 1994.
- Treatment of Acute Ischemic Stroke (Brain Attack) Questions and AnswersCreated: May 1998.
- Treatment of Obstructive Sleep Apnea in AdultsCreated: June 1999.
- Executive Summary
- Background
- Evaluation of the Evidence
- Diagnosis and Monitoring of Obstructive Sleep Apnea
- Treatment of Obstructive Sleep Apnea
- Costs and Cost-Effectiveness
- Findings and Conclusions
- Recommendations
- Appendix I: Definitions
- Appendix II: Methodology
- Appendix III: Guidelines
- Appendix IV: Summary of Concusions by the Agency for Health Care Policy and Research (AHCPR)
- Appendix V: Public Comment
- References
- Universal Newborn Hearing ScreeningCreated: July 1997.
- Use Of Botulinum Toxin-A In Pain Associated with Neuromuscular DisordersCreated: July 2001.
- Executive Summary
- Introduction
- Focal Dystonia with Pain
- Spastic Disease States with Pain
- Patient Selection Criteria
- Evaluation of Evidence
- Efficacy
- Safety
- Cost and Cost-effectiveness
- Alternative Treatments
- Issues of Controversy
- Future of Procedure
- Conclusions
- Appendix I: Methodology
- Appendix II: Summary of Studies
- References
- The Use of Human Growth Hormone for Children with Idiopathic Short StatureCreated: February 2000.
- Executive Summary
- Background
- Evaluation of Evidence
- Efficacy
- Safety
- Cost and Cost-Effectiveness
- Issues of Controversy
- Ethical Issues
- Insurance Coverage
- Conclusions
- Recommendations
- Appendix I: FDA - Approval Status of rhGH Products
- Appendix II: Summary of Studies on Human Growth Hormone for Children with Idiopathic Short Stature
- Appendix III: Search Strategy
- Appendix IV: Government Agencies and Professional Associations
- Appendix V: Public Comment
- Appendix VI: Summary of Guidelines for Diagnosis, Monitoring, and Treatment
- References
- Minnesota Health Technology AssessmentsMinnesota Health Technology Assessments
Your browsing activity is empty.
Activity recording is turned off.
See more...